Radio labeled dihematoporphyrin ether and its use in detecting and treating neoplastic tissue
CA 1337986 C · Owner: University Of Cincinnati · Inventors: Gluckman, Jack L.; Chen, I-Wen; Maxon, Harry R. Iii
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Radiolabeled dihematoporphyrin ether having the following general formula, wherein at least one of R1-R6 is a moiety labeled with a radionuclide imaging agent is useful in providing a non-invasive nuclear scintillation image. This dihematoporphyrin ether localizes in neoplastic tissue and thus provides a method of imaging and recording the location of neoplastic tissue. When the labeling agent has an adequate component of particulate radiation, the dihematoporphyrin ether can be used as a therapeutic agent as well as a diagnostic imaging agent.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted January 23, 1996. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended January 23, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.